Hypotensive episodes if administered too rapidly. Avoid paravenous leakage. Careful monitoring of Fe status, hematologic & anti-anemia parameters (Hb, hematocrit, serum ferritin & transferrin saturation); w/held therapy in patients w/ evidence of Fe overload. Patients w/ liver dysfunction; hepatic dysfunction; acute or chronic infection. Stop administration in patients w/ ongoing bacteremia. Avoid in patients w/ hepatic dysfunction. Pregnancy & lactation. Childn.